Syros Pharmaceuticals, Inc.
NASDAQ:SYRS
2.61 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||
| Net Income
| -164.574 | -94.654 | -86.558 | -84.038 | -75.438 | -62.279 | -54.01 | -47.743 | -29.818 | -13.431 | -8.665 |
| Depreciation & Amortization
| 2.252 | 2.967 | 3.018 | 3.035 | 2.722 | 1.604 | 1.527 | 1.273 | 0.602 | 0.258 | 0.17 |
| Deferred Income Tax
| -5.133 | 0 | -16.458 | 0.326 | -1.13 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 10.434 | 11.41 | 10.354 | 10.939 | 9.839 | 6.61 | 4.419 | 4.234 | 3.233 | 0.937 | 0.821 |
| Change In Working Capital
| 5.055 | -5.517 | -10.602 | 10.052 | -3.483 | 14.392 | 3.437 | 1.69 | 2.936 | 0.267 | 0.086 |
| Accounts Receivables
| 1.694 | 1.285 | 0.007 | 19.993 | -20.158 | 0 | 0.867 | -0.317 | 0 | 0 | 0 |
| Inventory
| 0 | -1.285 | 1.984 | -2.533 | -4.359 | 0 | 3.299 | 2.695 | 0 | 0 | 0 |
| Accounts Payables
| 5.133 | 2.766 | 0.048 | -1.057 | 1.493 | 0.888 | 0.141 | -0.404 | 2.022 | 0.334 | 0 |
| Other Working Capital
| -1.772 | -8.283 | -12.641 | -6.351 | 19.541 | 13.504 | -0.87 | -0.284 | 0.914 | -0.067 | 0.086 |
| Other Non Cash Items
| 42.194 | -37.271 | 0.706 | 2.322 | 7.237 | -0.642 | -0.102 | 0.01 | 0.017 | 0.334 | 0.394 |
| Operating Cash Flow
| -109.772 | -123.065 | -99.54 | -57.364 | -60.253 | -40.315 | -44.729 | -40.536 | -23.03 | -11.969 | -7.194 |
| Investing Activities: | |||||||||||
| Investments In Property Plant And Equipment
| -0.272 | -1.241 | -1.245 | -3.336 | -12.638 | -1.384 | -0.821 | -2.322 | -1.176 | -0.201 | -0.878 |
| Acquisitions Net
| 1.56 | 0 | 0 | 0 | 0.11 | 0.009 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -50.968 | 0 | -51.408 | 0 | -108.206 | -96.768 | -41.77 | -25.02 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 87.017 | 68.426 | 0 | 50 | 109 | 87.5 | 27 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 37.609 | 68.426 | -51.408 | 50 | 0.904 | 0.009 | -14.77 | -25.02 | 0 | 0 | 0 |
| Investing Cash Flow
| 37.337 | 67.185 | -52.653 | 46.664 | -11.734 | -10.643 | -15.591 | -27.342 | -1.176 | -0.201 | -0.878 |
| Financing Activities: | |||||||||||
| Debt Repayment
| -0.065 | -0.291 | -0.265 | -39.378 | -0.205 | -0.05 | -0.168 | -0.135 | -0.05 | 0 | 0 |
| Common Stock Issued
| 43.527 | 119.761 | 70.776 | 103.782 | 61.183 | 69.134 | 34.105 | 53.875 | 0.392 | 0.015 | 0 |
| Common Stock Repurchased
| 0.257 | 0.217 | 0 | 0.433 | 0.161 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 43.527 | 11.358 | 70.776 | 103.575 | 5.012 | 69.134 | 34.105 | 36.817 | -0.62 | 68.747 | 10.045 |
| Financing Cash Flow
| 43.462 | 131.045 | 70.511 | 142.953 | 65.99 | 69.084 | 33.937 | 90.557 | -0.278 | 68.762 | 10.045 |
| Other Information: | |||||||||||
| Effect Of Forex Changes On Cash
| 0.967 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -27.941 | 75.165 | -81.682 | 132.253 | -5.997 | 18.126 | -26.383 | 22.679 | -24.484 | 56.592 | 1.973 |
| Cash At End Of Period
| 139.526 | 170.553 | 95.388 | 177.07 | 44.817 | 50.814 | 32.205 | 58.588 | 35.909 | 60.393 | 3.801 |